Rankings
▼
Calendar
BDSX
Biodesix, Inc.
$138M
FY 2018 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$20M
Gross Profit
$16M
78.4% margin
Operating Income
-$23M
-114.8% margin
Net Income
-$26M
-128.1% margin
EPS (Diluted)
$-19.80
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$142,000
Balance Sheet
Total Assets
$39M
Total Liabilities
$237M
Stockholders' Equity
-$198M
Cash & Equivalents
$6M
← Q1 2018
All Quarters
BDSX FY 2018 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena